Contrary to reports, the UK CTA is not suing EU over novel food rules

Written by Freddie Dawson || 20th March 2019 || Regulatory briefing |

EU

United Kingdom

Regulation and Legislation

Regulatory briefing

Lawyers for the UK Cannabis Trades Association (CTA) have confirmed to CBD-Intel that they have not been instructed to sue the EU over novel food guidance for cannabinoids including CBD – contrary to reports ...

Swiss company plans final appeal against 25% tax on cannabis flowers

Written by Freddie Dawson || 19th March 2019 || Regulatory briefing |

Europe

Switzerland

Companies

Regulation and Legislation

Regulatory briefing

An appeal is planned against a Swiss court’s decision that low-THC cannabis flowers should continue to be taxed at the same 25% rate as fine-cut tobacco – a decision that came as no surprise to most Swiss CBD...

There’s room yet for growth and untangling in Canada’s legal reform

Written by CBD-Intel || 18th March 2019 || Regulatory briefing |

Canada

North America

Companies

Policy and Politics

Regulation and Legislation

Regulatory briefing

Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains ...

Will European authorities change their view of cannabinoids?

Written by Freddie Dawson || 15th March 2019 || Regulatory briefing |

EU

Europe

United Kingdom

Policy and Politics

Regulation and Legislation

Regulatory briefing

Lobbyists have highlighted flaws in European authorities’ current classification of cannabinoids as novel foods which could signal change ...

Status and future of CBD oil in Sweden is in the lap of the courts

Written by CBD-Intel || 12th March 2019 || Regulatory briefing |

EU

Europe

Sweden

Regulation and Legislation

Regulatory briefing

The future of CBD oil in Sweden is about to be decided as several cases inch their way through the country’s administrative courts ...

French CBD users warned against buying from illicit online suppliers

Written by CBD-Intel || 7th March 2019 || Regulatory briefing |

EU

Europe

France

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The French Medicines Agency (Agence Nationale du Médicament, ANSM) has issued a warning to consumers against buying illicit CBD products online ...

More regulatory doubts over CBD in US as FDA commissioner steps down

Written by Freddie Dawson || 7th March 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The resignation of Food and Drug Administration (FDA) commissioner Scott Gottlieb adds further uncertainty to the future of federal oversight of CBD in the US ...

State by state, US Farm Bill delivers different strokes for different folks

Written by Daniel Mollenkamp || 4th March 2019 || Regulatory briefing |

Colorado

New York

North America

Pennsylvania

Puerto Rico

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth ...

FDA jurisdiction still unchallenged – but industry presses for clarity

Written by CBD-Intel || 1st March 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The US Food and Drug Administration is moving slowly in drawing regulatory boundaries for CBD businesses. Members of Congress have called for clarity, but the FDA says it has no plans to give cannabis derivatives the green light...

CBD in foods: UK FSA set to issue guidance

Written by Freddie Dawson || 1st March 2019 || Regulatory briefing |

England

Europe

United Kingdom

Wales

Marketing and Retailing

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The UK Food Standards Agency (FSA) will issue further guidance next week on the use of cannabinoids as novel food ingredients ...

FDA sets the date for hearing on legalising hemp-derived CBD

Written by CBD-Intel || 1st March 2019 || Regulatory briefing |

California

Maine

North America

United States

Wisconsin

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner...

Swiss report signals ‘the beginning of the end of cannabis prohibition’

Written by CBD-Intel || 28th February 2019 || Regulatory briefing |

Europe

Switzerland

Policy and Politics

Regulation and Legislation

Regulatory briefing

Growing acceptance and use of CBD in Switzerland, as demonstrated in a recent report, could eventually lead to legalisation of cannabis in the country, according to a range of experts ...

First cases of CBD shops allowed to reopen, but France remains confused

Written by CBD-Intel || 27th February 2019 || Regulatory briefing |

EU

Europe

France

Regulation and Legislation

Regulatory briefing

The French CBD market looks more promising as shops shut down last year through legal action have begun to re-open – though elsewhere in the country others are still being closed and their owners prosecuted ...

Confusion abounds in the tangle of US states’ CBD enforcement

Written by Daniel Mollenkamp || 26th February 2019 || Regulatory briefing |

Alabama

Idaho

Maine

Michigan

Nebraska

New York

North America

Ohio

South Carolina

Tennessee

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Momentum in the American CBD market continues to build, but a confusing patchwork of differing interpretations by various state authorities has led to local officials starting to clamp down on retailers ...

UN narcotics committee postpones vote on CBD and cannabis rules

Written by Freddie Dawson || 26th February 2019 || Regulatory briefing |

Asia

Europe

Japan

Norway

South America

Uruguay

World

Policy and Politics

Regulation and Legislation

Regulatory briefing

The United Nations Committee on Narcotic Drugs (UNCND) has delayed voting on cannabis and CBD recommendations in a move that has upset a number of delegates ...

How will Spanish elections change the outlook for CBD and cannabis?

Written by Pablo Cano Trilla || 26th February 2019 || Regulatory briefing |

Europe

Spain

Policy and Politics

Regulation and Legislation

Regulatory briefing

Whether the left or the right ends up in power – and that is difficult to predict – some form of debate around cannabis could be on the cards following forthcoming general elections in Spain ...

International packaging and disposal standards give guide to compliance

Written by Freddie Dawson || 25th February 2019 || Regulatory briefing |

North America

United States

World

Regulation and Legislation

Regulatory briefing

Proper disposal of cannabis raw materials forms a major part of new work from ASTM International, US-based developer of international voluntary technical standards ...

Proposal to clarify CBD products’ legality goes to Lithuanian parliament

Written by Freddie Dawson || 20th February 2019 || Regulatory briefing |

Europe

Lithuania

Regulation and Legislation

Regulatory briefing

Lithuania could buck current European trends and legislate to allow CBD food products. A new bill allowing edibles with less than 0.2% THC content has been proposed in the country’s parliament ...

Singapore ministries declare cannabis mad, bad and dangerous

Written by Freddie Dawson || 18th February 2019 || Regulatory briefing |

Asia

Singapore

Policy and Politics

Regulation and Legislation

Regulatory briefing

Singaporean authorities do not believe there is sufficient evidence supporting the efficacy of “raw” cannabis, considering the plant and its derivatives to be a dangerous drug with few medical benefits ...

WHO recommends removing CBD from world narcotics schedules

Written by Barnaby Page || 18th February 2019 || Regulatory briefing |

World

Regulation and Legislation

Regulatory briefing

CBD is likely to be removed from the scope of the most significant international treaty on drug control, following a favourable report by the World Health Organization (WHO), which also recommends downgrading cannabis ...

Czechs may get medical cannabis 90% covered by public insurance

Written by Freddie Dawson || 18th February 2019 || Regulatory briefing |

Czech Republic

Europe

Regulation and Legislation

Regulatory briefing

The health authorities in the Czech Republic are considering a proposal to cover up to 90% of the cost of medical cannabis through public insurance ...

CBD foods can’t be made in Italy, health ministry confirms

Written by CBD-Intel || 18th February 2019 || Regulatory briefing |

EU

Europe

Italy

Regulation and Legislation

Regulatory briefing

The production of foods containing cannabinoids is not permitted in Italy, the country’s health ministry has confirmed to CBD-Intel ...

Europe votes for medical cannabis – in theory and on certain conditions

Written by CBD-Intel || 14th February 2019 || Regulatory briefing |

EU

Europe

Policy and Politics

Regulation and Legislation

Regulatory briefing

The European Parliament has passed a resolution supporting medical cannabis – though only in cases where a product has gone through clinical trials and a regulatory approval process ...

Confusion reigns in Austria over novel food status of CBD products

Written by CBD-Intel || 12th February 2019 || Regulatory briefing |

Austria

EU

Europe

Regulation and Legislation

Regulatory briefing

No one in Austria wants to take responsibility for the enforcement and clarification of CBD regulations as Austrian and European officials appear to be working at cross purposes to implement new rulings ...

Rumour sparks selling like hot cakes, but Austria plans no new clampdown

Written by CBD-Intel || 12th February 2019 || Regulatory briefing |

Austria

EU

Europe

Regulation and Legislation

Regulatory briefing

The Austrian government is to review the enforcement of rules on CBD, but stricter interpretations are not expected despite recent rumours and the fears of some sellers of CBD products ...

‘No change to UK novel food rules’ after Brexit

Written by CBD-Intel || 8th February 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Regulation and Legislation

Regulatory briefing

The UK’s Food Standards Agency has said there will be no change in UK regulations concerning CBD as a novel food ingredient should the UK leave the EU on 29th March ...

Israel gears up for trade after cannabis export law is passed

Written by CBD-Intel || 5th February 2019 || Regulatory briefing |

Asia

Israel

Companies

Policy and Politics

Regulation and Legislation

Regulatory briefing

Israeli firms will soon be able to export medical cannabis and some derived medical cannabis products after a bill was passed establishing a licensing and supervision regime ...

Knotty regulation keeps CBD traffic still tied up on state lines

Written by Freddie Dawson || 4th February 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Despite the 2018 Farm Act, CBD companies hoping for a national market in the US are still hampered by federal regulations, with products prevented from being sold across state lines ...

US veterans urge CBD legalisation in Georgia, Tennessee drafts CBD bills

Written by Daniel Mollenkamp || 28th January 2019 || Regulatory briefing |

Georgia

North America

Tennessee

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Congressional politicians in Tennessee have been turning their attention to possible regulation of farming for CBD, while those in Georgia have been addressed by military veterans eager for CBD to be legalised ...

Italian bid to legalise homegrown cannabis ‘won’t affect CBD’

Written by Freddie Dawson || 23rd January 2019 || Regulatory briefing |

Europe

Italy

Policy and Politics

Regulation and Legislation

Regulatory briefing

A proposal before the Italian government to legalise personal cultivation and possession of cannabis would also allow cannabis flowers with THC concentrations of up to 1% in foods and as a herbal product ...

Wyoming CBD legalisation bill falls at House committee hurdle

Written by Freddie Dawson || 23rd January 2019 || Regulatory briefing |

North America

United States

Wyoming

Regulation and Legislation

Regulatory briefing

Wyoming is unlikely to join the long list of US states permitting the legal use of CBD after a bill proposing legalisation failed to pass through the Republican-controlled state House’s judiciary committee ...

Radical change in EU guidance on cannabinoids as novel food

Written by Freddie Dawson || 22nd January 2019 || Regulatory briefing |

EU

Europe

Policy and Politics

Regulation and Legislation

Regulatory briefing

No food item should contain any cannabinoid, including CBD, in the EU without prior novel food ingredient authorisation following a change by European authorities - though this is open to interpretation ...

Michigan takes lead in distinguishing low-THC CBD from medical cannabis

Written by Freddie Dawson || 22nd January 2019 || Regulatory briefing |

Michigan

North America

United States

Regulation and Legislation

Regulatory briefing

Michigan legislators have passed what is thought to be the first US law specifically exempting CBD products from state medical cannabis regulations ...

Where in the world are the countries most likely to legalise cannabis?

Written by Barnaby Page || 17th January 2019 || Regulatory briefing |

Africa

Asia

Australasia

Canada

Europe

Mexico

New Zealand

North America

South America

United States

World

Policy and Politics

Regulation and Legislation

Regulatory briefing

Researchers in Portugal have developed an algorithm to identify characteristics that suggest the nations most likely to legalise recreational cannabis ...

Is FDA taking action on CBD products ‘for human consumption’?

Written by Freddie Dawson || 17th January 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

An unconfirmed seizure of products from a shop in Arizona could be the first instance of enforcement on CBD by Food and Drug Administration (FDA) officials since the passage of the US 2018 Farm Bill ...

Canada puts forward new proposals for cannabis product regulations

Written by Freddie Dawson || 16th January 2019 || Regulatory briefing |

Canada

North America

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Canadian government has released proposed regulations for additional products containing cannabis-derived ingredients, including food items, beverages, extracts and topicals ...

Change in law could open up New Zealand for CBD business

Written by CBD-Intel || 15th January 2019 || Regulatory briefing |

Australasia

New Zealand

Regulation and Legislation

Regulatory briefing

New Zealand could become a new market for CBD following loosening of restrictions in the country, explained in a new report from CBD-Intel ...

Italian agriculture ministry seeks to end confusion over THC limits

Written by CBD-Intel || 9th January 2019 || Regulatory briefing |

EU

Europe

Italy

Regulation and Legislation

Regulatory briefing

The Italian government has responded to confusion over permitted THC levels in hemp-derived products such as foods, oils, supplements and animal feeds by informing the European Commission of its plans ...

Health claims in ads for CBD products: the UK rules interpreted

Written by Freddie Dawson || 8th January 2019 || Regulatory briefing |

Europe

United Kingdom

Regulation and Legislation

Regulatory briefing

When can a health claim be made in an advertisement for a CBD product in the UK? CBD-Intel considers how the advertising codes may be legally applied in practice ...

New Congress, new outlook for the legal status of cannabis

Written by CBD-Intel || 3rd January 2019 || Regulatory briefing |

Canada

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The US Congress is expected to address the legal situation of CBD and cannabis during the upcoming congressional session, according to a number of experts interviewed by CBD-Intel ...

How changes in US Congress brighten the outlook for cannabis law reform

Written by Freddie Dawson || 2nd January 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Pro-cannabis measures are expected to receive at least 18 more votes of support in the new US Congress, according to exclusive research by CBD-Intel, with more than 60 new Representatives supporting legalisation ...

We still regulate foods and health claims, FDA reminds US CBD industry

Written by Barnaby Page || 23rd December 2018 || Regulatory briefing |

North America

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned ...

Austria confirms ban on use of CBD in cosmetics

Written by Barnaby Page || 23rd December 2018 || Regulatory briefing |

Austria

Europe

Regulation and Legislation

Regulatory briefing

The use of any cannabis extract in cosmetics is forbidden in Austria, authorities have recently confirmed ...

New York state sets out new rules for manufacture of CBD products

Written by Freddie Dawson || 17th December 2018 || Regulatory briefing |

New York

North America

United States

Regulation and Legislation

Regulatory briefing

New York state has set out a series of new regulatory requirements for businesses wanting to produce or sell CBD products in its jurisdiction, with strict manufacturing, reporting and product category guidelines ...

Congress passes US Farm Bill with Hemp Farming Act intact

Written by Daniel Mollenkamp || 14th December 2018 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The US Congress has approved a compromise version of the 2018 Farm Bill which will remove industrial hemp from the federal narcotics Schedule 1 list, potentially giving a green light to development of the CBD industry ...

Canadian company threatened with loss of its medical cannabis licence

Written by CBD-Intel || 13th December 2018 || Regulatory briefing |

Canada

North America

Companies

Regulation and Legislation

Regulatory briefing

A Canadian company is facing the prospect of losing its licence to produce and sell cannabis products. It would mark the first time Health Canada has revoked a licence since the country began regulating medical marijuana ...

French Kanavape case is referred to the European Court of Justice

Written by CBD-Intel || 6th December 2018 || Regulatory briefing |

EU

Europe

France

Regulation and Legislation

Regulatory briefing

A case on the legality of selling CBD-based products in France has been referred to the Court of Justice of the European Union (CJEU) ...

Tests find labels on oil mis-state THC levels – sometimes dangerously

Written by CBD-Intel || 29th November 2018 || Regulatory briefing |

Czech Republic

Europe

Public Health and Medicine

Regulatory briefing

Most European CBD oils label their CBD content correctly but comparatively few are accurate about THC, a study in the Czech Republic has found ...

What will Brexit really mean for the British CBD industry?

Written by CBD-Intel || 19th November 2018 || Regulatory briefing |

EU

Europe

United Kingdom

Policy and Politics

Regulation and Legislation

Regulatory briefing

The British government last week presented the 585-page draft withdrawal agreement which lays out how it intends the UK to leave the European Union. Here CBD-Intel explains just how it may affect the CBD industry ...

Exit Sessions – could the departure of the AG be good news for cannabis?

Written by Daniel Mollenkamp || 15th November 2018 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

With the ousting of attorney general Jeff Sessions from the Trump administration, members of the US cannabis industry have perked up, hoping the anti-cannabis agenda will exit with him ...